Ensign Peak Advisors, Inc Moderna, Inc. Transaction History

Ensign Peak Advisors, Inc

$51.2 Billion
Q1 2025

A detailed history of Ensign Peak Advisors, Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 94,615 shares of MRNA stock, worth $2.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

94,615

Previous 67,819 39.51%

Holding current value

$2.7 Million

Previous $2.82 Million 4.86%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$28.35 - $47.53 $759,666 - $1.27 Million	26,796 Added 39.51%	94,615 $2.68 Million
Q4 2024 Feb 13, 2025	SELL	$36.85 - $63.93 $28,374 - $49,226	-770 Reduced 1.12%	67,819 $2.82 Million
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $284,789 - $560,001	-4,475 Reduced 6.12%	68,589 $4.58 Million
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $8.12 Million - $13.4 Million	-80,198 Reduced 52.33%	73,064 $8.68 Million
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $4.81 Million - $6.51 Million	56,350 Added 58.15%	153,262 $16.3 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $1.02 Million - $1.54 Million	14,735 Added 17.93%	96,912 $9.64 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $3.87 Million - $5.09 Million	40,185 Added 95.7%	82,177 $8.49 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $12.7 Million - $17.2 Million	-107,060 Reduced 71.83%	41,992 $5.1 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $3.95 Million - $5.74 Million	29,110 Added 24.27%	149,052 $22.9 Million
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $7.5 Million - $13.3 Million	63,368 Added 112.01%	119,942 $21.5 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $5.3 Million - $8.72 Million	-44,905 Reduced 44.25%	56,574 $6.69 Million
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $570,423 - $859,993	4,870 Added 5.04%	101,479 $14.5 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $6.9 Million - $12.8 Million	54,600 Added 129.97%	96,609 $16.6 Million
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $8.55 Million - $13.9 Million	-37,848 Reduced 47.39%	42,009 $10.7 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $14.5 Million - $31.7 Million	65,392 Added 452.07%	79,857 $30.7 Million
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $1.8 Million - $3.25 Million	-13,845 Reduced 48.9%	14,465 $3.4 Million
Q1 2021 May 12, 2021	SELL	$109.18 - $185.98 $571,775 - $973,977	-5,237 Reduced 15.61%	28,310 $3.71 Million
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $2.77 Million - $7.16 Million	-42,148 Reduced 55.68%	33,547 $3.5 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $998,497 - $1.74 Million	18,375 Added 32.06%	75,695 $5.36 Million
Q2 2020 Aug 12, 2020	BUY	$29.67 - $80.0 $1.7 Million - $4.59 Million	57,320 New	57,320 $3.68 Million

Others Institutions Holding MRNA

# of Institutions

861

Shares Held

267M

Call Options Held

28.5M

Put Options Held

34.8M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $11.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Moderna, Inc. Transaction History